Legend Biotech Corporation

NASDAQ:LEGN

Biotechnology

Healthcare
$16.10 -13.51%

-$4.53 today

Market cap
$2.98B
Beta
0.35
P/E (TTM)
-21.4
EPS (TTM)
-$1.35
52W Low $16.24High $45.30

Volume 2.37M

Average 2.42M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

-$100.47M

FY 2025 · Annual

Investing Cash Flow

$711.48M

FY 2025 · Annual

Financing Cash Flow

-$300,793.00

FY 2025 · Annual

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(407.2M)(445.72M)(520.12M)(158.13M)(297.58M)
Depreciation & Amortization13.92M18.39M20.45M23.36M28.9M
Deferred Income Tax00000
Stock-Based Compensation20.16M34.34M47.68M68.94M0
Change in Working Capital161.83M181.03M(71.34M)20.04M(93.35M)
Accounts Receivables24.59M50.32M(98.98M)93.75M(132.85M)
Inventory51K(13.89M)(12.71M)(17.21M)(4.51M)
Accounts Payables1.81M72.45M(50.2M)14.06M44.52M
Other Working Capital135.39M72.16M90.54M(70.57M)(501.32K)
Other Non-Cash Items12.82M10.68M130.06M(98.24M)261.57M
Operating Cash Flow(198.47M)(201.28M)(393.28M)(144.03M)(100.47M)
Capital Expenditures(45.4M)(22.28M)(22.72M)(14.11M)(67.58M)
Acquisitions (Net)00000
Purchases of Investments(377.96M)(654.97M)(4.86B)(2.71B)(4.55B)
Sales of Investments230.08M614.86M5.08B1.93B5.33B
Other Investing Activities(4.91M)(16.05M)(100.52M)(54.34M)0
Investing Cash Flow(194.98M)(77.09M)92.79M(850.54M)711.48M
Debt Repayment(1.42M)(2.6M)(3.76M)(4.02M)0
Common Stock Issued623.44M377.64M003.31M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities4.64M2.93M795.25M9.72M(3.61M)
Financing Cash Flow626.66M377.98M791.49M5.7M(300.79K)
Effect of Forex Changes34K(2.51M)682K(2.09M)4.37M
Net Change in Cash233.25M97.09M491.68M(990.96M)615.09M
Free Cash Flow(243.87M)(223.56M)(416M)(158.14M)(168.04M)

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income-$297.6M
+ D&A$28.9M
+ Stock-Based Comp$0
+ Deferred Tax$0
- Working Capital-$93.3M
+ Other Non-Cash$261.6M
= Operating Cash Flow-$100.5M
- Capex-$67.6M
= Free Cash Flow-$168.0M

Analysis

FY2025 free cash flow is -$168.0M. FCF conversion is 56.5% of net income. Operating cash flow was -$100.5M, with capex of -$67.6M. The largest bridge item is Other Non-Cash at $261.6M.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
6-K6-K filingNov 10, 2026
SC 13G/ASC 13G/A filingNov 5, 2026
6-K6-K filingNov 4, 2026
6-K6-K filingOct 15, 2026
6-K6-K filingOct 13, 2026

Does LEGN generate free cash flow?

Legend Biotech Corporation (LEGN) generated -$168.04M of free cash flow in fiscal 2025.

How much operating cash flow does LEGN produce?

Operating cash flow was -$100.47M, before capital expenditures of $67.58M.